Morton Collins, Director at INOVIO PHARMACEUTICALS, INC. (INO), bought 21,300 shares at $6.25 ($133K) on 2017-03-27, disclosed to the SEC on 2017-03-28.
Open-market purchase of $133k INO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| INO | BUY | 2016-06-29 | $183K | — | Filing → |
| KOPN | BUY | 2016-05-20 | $106K | — | Filing → |
| INO | BUY | 2016-04-18 | $710K | — | Filing → |